Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas Meeting Abstract


Authors: Sait, S. F.; Rosenblum, M.; Bale, T.; Haque, S.; Gilheeney, S.; Spatz, K.; Prince, D.; Ibanez, K.; Dunkel, I.; Karajannis, M.
Abstract Title: Debio1347, an oral FGFR inhibitor: Results from a single center study in pediatric patients with recurrent/refractory FGFR altered gliomas
Meeting Title: 25th Virtual Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 22
Issue: Suppl. 2
Meeting Dates: 2020 Nov 19-21
Meeting Location: Virtual Conference
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2020-11-01
Start Page: ii50
Language: English
ACCESSION: WOS:000590061300201
PROVIDER: wos
DOI: 10.1093/neuonc/noaa215.200
Notes: Meeting Abstract: CTNI-33 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel
  2. Marc Rosenblum
    424 Rosenblum
  3. Sofia S Haque
    148 Haque
  4. Katarzyna   Ibanez
    17 Ibanez
  5. Daniel Eduardo Prince
    19 Prince
  6. Tejus Bale
    122 Bale